• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chronic myelogenous leukemia: ESMO clinical recommendations for the diagnosis, treatment and follow-up.

作者信息

Hochhaus A, Dreyling M

机构信息

III. Medizinische Klinik, Medizinische Fakultaet Mannheim, Universitaet Heidelberg, Mannheim, Germany.

出版信息

Ann Oncol. 2008 May;19 Suppl 2:ii63-4. doi: 10.1093/annonc/mdn091.

DOI:10.1093/annonc/mdn091
PMID:18456772
Abstract
摘要

相似文献

1
Chronic myelogenous leukemia: ESMO clinical recommendations for the diagnosis, treatment and follow-up.慢性粒细胞白血病：ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2008 May;19 Suppl 2:ii63-4. doi: 10.1093/annonc/mdn091.
2
Chronic myelogenous leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up.慢性粒细胞白血病：ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2009 May;20 Suppl 4:105-7. doi: 10.1093/annonc/mdp143.
3
ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of chronic myelogenous leukemia (CML).
Ann Oncol. 2005;16 Suppl 1:i52-3. doi: 10.1093/annonc/mdi807.
4
Chronic myelogenous leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Ann Oncol. 2007 Apr;18 Suppl 2:ii51-2. doi: 10.1093/annonc/mdm035.
5
Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.慢性髓性白血病：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2010 May;21 Suppl 5:v165-7. doi: 10.1093/annonc/mdq201.
6
Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.慢性髓性白血病：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2017 Jul 1;28(suppl_4):iv41-iv51. doi: 10.1093/annonc/mdx219.
7
Long-term follow-up of children with chronic myeloid leukemia after hematopoietic stem cell transplantation and tyrosine kinase inhibitor therapy.
Leuk Lymphoma. 2016;57(4):949-52. doi: 10.3109/10428194.2015.1065981. Epub 2015 Dec 23.
8
Potential clinical implications of early diagnosis of chronic myeloid leukemia.
Haematologica. 1999 Apr;84(4):289-90.
9
[Chronic myeloid leukemia--contemporary diagnosis and treatment possibilities].
Pol Arch Med Wewn. 2001;105 Suppl:391-4.
10
Clinical and epidemiologic burden of chronic myelogenous leukemia.慢性粒细胞白血病的临床和流行病学负担
Expert Rev Anticancer Ther. 2004 Feb;4(1):85-96. doi: 10.1586/14737140.4.1.85.

引用本文的文献

1
Oxidative Stress and Chronic Myeloid Leukemia: A Balance between ROS-Mediated Pro- and Anti-Apoptotic Effects of Tyrosine Kinase Inhibitors.氧化应激与慢性髓系白血病：酪氨酸激酶抑制剂的ROS介导的促凋亡和抗凋亡作用之间的平衡
Antioxidants (Basel). 2024 Apr 13;13(4):461. doi: 10.3390/antiox13040461.
2
Extracellular vesicles in the Chronic Myeloid Leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules.慢性髓性白血病中的细胞外囊泡：疾病标志物与治疗分子转运的最新进展
Front Oncol. 2024 Jan 8;13:1239042. doi: 10.3389/fonc.2023.1239042. eCollection 2023.
3
Population-Based Testing and Treatment Characteristics for Chronic Myelogenous Leukemia.
慢性粒细胞白血病的基于人群的检测与治疗特征
J Registry Manag. 2016 Fall;41(3):134-142.
4
miRNAs as Biomarkers in Chronic Myelogenous Leukemia.微小RNA作为慢性粒细胞白血病的生物标志物
Drug Dev Res. 2015 Sep;76(6):278-85. doi: 10.1002/ddr.21266. Epub 2015 Aug 18.
5
Influence of CYP1A1, GST polymorphisms and susceptibility risk of chronic myeloid leukemia in Syrian population.叙利亚人群中CYP1A1、GST基因多态性对慢性髓性白血病易感性风险的影响。
Med Oncol. 2014 May;31(5):889. doi: 10.1007/s12032-014-0889-4. Epub 2014 Mar 27.
6
Monitoring response and resistance to treatment in chronic myeloid leukemia.监测慢性髓性白血病的治疗反应和耐药性。
Curr Oncol. 2011 Apr;18(2):e71-83. doi: 10.3747/co.v18i2.391.
7
Suboptimal response to or failure of imatinib treatment for chronic myeloid leukemia: what is the optimal strategy?慢性髓性白血病对伊马替尼治疗反应欠佳或治疗失败：最佳策略是什么？
Mayo Clin Proc. 2009 Feb;84(2):161-9. doi: 10.4065/84.2.161.